Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

PLM-101

Product Specifications

Target

Others, FLT, c-RET

Related Pathways

Angiogenesis, Tyrosine Kinase/Adaptors, Others, Apoptosis

Bioactivity

PLM-101 is an anticancer compound orally active against acute myeloid leukemia by targeting FLT3 and RET. It impedes RET function, promoting autophagic breakdown of FLT3, and suppresses the PI3K and Ras/ERK pathways, contributing to its anti-leukemic effects. The compound's antitumor efficacy is demonstrated in both a mouse MV4-11 flank xenograft model (doses of 3 and 10 mg/kg; po) and an allogeneic xenograft mouse model (dose of 40 mg/kg; po) [1].

Molecular Formula

C22H22FN5O2

Molecular Weight

407.44

Shipping Conditions

Ice Packs

Storage Temperature

-20°C

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Fmoc-Acp-2-Chlorotrityl Resin
5-07994 100 g

Fmoc-Acp-2-Chlorotrityl Resin

Sign In for Pricing
View Details
ZNF588 shRNA (h) Lentiviral Particles
sc-89509-V 200 µL

ZNF588 shRNA (h) Lentiviral Particles

Sign In for Pricing
View Details
Mouse Monoclonal FGF-19 Antibody (MM0285-4G16) [FITC]
NBP2-12299F 0.1 mL

Mouse Monoclonal FGF-19 Antibody (MM0285-4G16) [FITC]

Sign In for Pricing
View Details
CD31 (APC)
MBS6268447-01 0.1 mL

CD31 (APC)

Sign In for Pricing
View Details
CD31 (APC)
MBS6268447-02 5x 0.1 mL

CD31 (APC)

Sign In for Pricing
View Details
SLC30A6 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)
44115061 1.0 µg DNA

SLC30A6 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

Sign In for Pricing
View Details